Risk of major bleeding and stroke associated with the use of vitamin K antagonists, nonvitamin K antagonist oral anticoagulants and aspirin in patients with atrial fibrillation: a cohort study

Emilie M. Gieling, Hendrika A. van den Ham*, Hein van Onzenoort, Jacqueline Bos, Cornelis Kramers, Anthonius de Boer, Frank de Vries, Andrea M. Burden

*Corresponding author for this work

Research output: Contribution to journalArticleAcademicpeer-review

Original languageEnglish
Pages (from-to)1844-1859
Number of pages16
JournalBritish Journal of Clinical Pharmacology
Volume83
Issue number8
DOIs
Publication statusPublished - Aug 2017

Keywords

  • anticoagulants
  • aspirin
  • atrial fibrillation
  • gastrointestinal haemorrhage
  • intracranial haemorrhage
  • stroke
  • HEART-RHYTHM-ASSOCIATION
  • WARFARIN
  • METAANALYSIS
  • DABIGATRAN
  • EFFICACY
  • SAFETY
  • RIVAROXABAN
  • POPULATION
  • TRIALS
  • PHARMACOLOGY

Cite this

@article{5e2d08b5516a441cb56450198cd3f0d8,
title = "Risk of major bleeding and stroke associated with the use of vitamin K antagonists, nonvitamin K antagonist oral anticoagulants and aspirin in patients with atrial fibrillation: a cohort study",
keywords = "anticoagulants, aspirin, atrial fibrillation, gastrointestinal haemorrhage, intracranial haemorrhage, stroke, HEART-RHYTHM-ASSOCIATION, WARFARIN, METAANALYSIS, DABIGATRAN, EFFICACY, SAFETY, RIVAROXABAN, POPULATION, TRIALS, PHARMACOLOGY",
author = "Gieling, {Emilie M.} and {van den Ham}, {Hendrika A.} and {van Onzenoort}, Hein and Jacqueline Bos and Cornelis Kramers and {de Boer}, Anthonius and {de Vries}, Frank and Burden, {Andrea M.}",
year = "2017",
month = "8",
doi = "10.1111/bcp.13265",
language = "English",
volume = "83",
pages = "1844--1859",
journal = "British Journal of Clinical Pharmacology",
issn = "0306-5251",
publisher = "Wiley",
number = "8",

}

Risk of major bleeding and stroke associated with the use of vitamin K antagonists, nonvitamin K antagonist oral anticoagulants and aspirin in patients with atrial fibrillation : a cohort study. / Gieling, Emilie M.; van den Ham, Hendrika A.; van Onzenoort, Hein; Bos, Jacqueline; Kramers, Cornelis; de Boer, Anthonius; de Vries, Frank; Burden, Andrea M.

In: British Journal of Clinical Pharmacology, Vol. 83, No. 8, 08.2017, p. 1844-1859.

Research output: Contribution to journalArticleAcademicpeer-review

TY - JOUR

T1 - Risk of major bleeding and stroke associated with the use of vitamin K antagonists, nonvitamin K antagonist oral anticoagulants and aspirin in patients with atrial fibrillation

T2 - a cohort study

AU - Gieling, Emilie M.

AU - van den Ham, Hendrika A.

AU - van Onzenoort, Hein

AU - Bos, Jacqueline

AU - Kramers, Cornelis

AU - de Boer, Anthonius

AU - de Vries, Frank

AU - Burden, Andrea M.

PY - 2017/8

Y1 - 2017/8

KW - anticoagulants

KW - aspirin

KW - atrial fibrillation

KW - gastrointestinal haemorrhage

KW - intracranial haemorrhage

KW - stroke

KW - HEART-RHYTHM-ASSOCIATION

KW - WARFARIN

KW - METAANALYSIS

KW - DABIGATRAN

KW - EFFICACY

KW - SAFETY

KW - RIVAROXABAN

KW - POPULATION

KW - TRIALS

KW - PHARMACOLOGY

U2 - 10.1111/bcp.13265

DO - 10.1111/bcp.13265

M3 - Article

VL - 83

SP - 1844

EP - 1859

JO - British Journal of Clinical Pharmacology

JF - British Journal of Clinical Pharmacology

SN - 0306-5251

IS - 8

ER -